Omeros Corporation today announced two presentations that will be featured at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...

"Having a fully running business model for the past year, we are now taking this significant step towards uplisting to OTCQB, ...

Spectral Capital Corporation , a deep quantum technology platform company, is pleased to announce the achievement of a second major patent milestone in its plan to become a globally competitive leader ...

After a fourth-quarter earnings miss and “subpar” outlook, National Bank Financial analyst Maxim Sytchev warns investors 2025 ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

Murine hematopoietic cells were transduced with ... after a maximal observation period of 37 weeks. Leukemic cell growth in methylcellulose and liquid culture, apoptosis assay and cell cycle ...

Background: Engraftment after hematopoietic stem cell transplantation is the recovery rate of neutrophils and platelets. This study aimed to test the impact of the patient's general characteristics, ...

Apple’s answer is an entire system, rather than a simple app-based or browser-based interface. Apple Intelligence aims to take a proactive approach to making its device owners’ lives easier ...